Recent Advances in Inflammation & Allergy Drug Discovery

(Recent Patents on Inflammation & Allergy Drug Discovery)

ISSN (Print): 2772-2708
ISSN (Online): 2772-2716

Volume 15, Issue 2, 2021

This journal supports open access

Back Journal Home
Topic(s) Covered

2 Topic(s)

View
Covered Disease(s)

1 Disease(s)

View

Aims & Scope

Recent Advances in Inflammation & Allergy Drug Discovery publishes full-length/mini-reviews, research articles, letters, case reports, perspectives, systematic reviews and thematic issues on inflammation and allergy research, including new strategies of diagnosis, treatment and prevention of allergic and inflammatory diseases. The journal covers all pharmacological aspects of inflammation and allergy, including mediators of inflammation and allergy, as well as cellular processes and molecular mechanisms involved in inflammation, immune dysfunction and allergies in every area of medicine. Articles on important and recent patents in the field are also included in the journal. The journal is essential reading for all researchers involved in inflammation and allergy drug design and discovery.

Abstracted/Indexed in


Cambridge Scientific Abstracts (CSA)/ProQuest, Chemical Abstracts Service/SciFinder, ChemWeb, CNKI Scholar, Dimensions, EBSCO, EMBASE, Emerging Sources Citation Index (ESCI) by Clarivate Analytics, Genamics JournalSeek, Google Scholar, J-Gate, JournalTOCs, MediaFinder®-Standard Periodical Directory, MEDLINE/PubMed, METADEX, Open Abstracts (I4OA), PubsHub, QOAM, Scilit, Scopus, Suweco CZ, TOC Premier and Ulrich's Periodicals Directory

Special Offers

Quick processing and publication of the submitted papers. The manuscript will be published online within 20 days of final acceptance.

30% discount on the single-issue cost to authors on the purchase of issue(s) in which their article is published.
Multiple issue copies at discounted rates.

Abstracted/Indexed in
COPE COMPLIANT
© 2022 Bentham Science Publishers | Privacy Policy